Quarterly Updates11 Nov 2025, 05:32 pm
Cosmo First Reports Q2 FY26 Results with 25% Sales Volume Growth and New Product Developments
AI Summary
Cosmo First Limited has declared its financial results for the quarter and half year ended September 30, 2025 (Q2 & H1 FY26). Q2 FY26 EBITDA improved due to higher sales volume and better performance of the specialty chemicals subsidiary. The company is expecting full utilization of new lines by Q4 FY26. During the quarter, the films business, chemicals business, rigid packaging, consumer business, petcare business, and CSR initiatives saw significant developments.
Key Highlights
- Q2 FY26 EBITDA improved by 20% on the back of higher sales volume and better performance of the specialty chemicals subsidiary.
- New lines expected to be fully utilized by Q4 FY26.
- Specialty chemical subsidiary developed 3 new products in the previous quarter.
- Cosmo Plastech focuses on achieving profitability through higher capacity utilization and improving costs/efficiency.
- Zigly and Cosmo Consumer businesses continue to scale-up.
- Cosmo Films commissioned an advanced KARO®IV Laboratory Stretching Machine and expanded in the US market.
- Cosmo Speciality Chemicals introduced performance-driven coating chemicals, masterbatches, and adhesives.
- Cosmo Plastech strengthened visibility through participation in exhibitions and launched advanced ESD PET sheet.
- Zigly Petcare strengthened national presence, announced the acquisition of Dr. Santa Animal Hospital, and expanded private-label portfolio.
- Cosmo Foundation celebrated World Youth Skills Day and collaborated with Pratham Book Champions for International Literacy Day.